New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets
Open accessThe DOI matches its Crossref record; 98 of the 99 references it cites were found in a registry or an index.
Abstract
To improve our ability to extrapolate preclinical toxicity to humans, there is a need to understand and quantify the concordance of adverse events (AEs) between animal models and clinical studies. In the present work, we discovered 3011 statistically significant associations between preclinical and clinical AEs caused by drugs reported in the PharmaPendium database of which 2952 were new associations between toxicities encoded by different Medical Dictionary for Regulatory Activities terms across species. To find plausible and testable candidate off-target drug activities for the derived associations, we investigated the genetic overlap between the genes linked to both a preclinical and a clinical AE and the protein targets found to interact with one or more drugs causing both AEs. We discuss three associations from the analysis in more detail for which novel candidate off-target drug activities could be identified, namely, the association of preclinical mutagenicity readouts with clinical teratospermia and ovarian failure, the association of preclinical reflexes abnormal with clinical poor-quality sleep, and the association of preclinical psychomotor hyperactivity with clinical drug withdrawal syndrome . Our analysis successfully identified a total of 77% of known safety targets currently tested in in vitro screening panels plus an additional 431 genes which were proposed for investigation as future safety targets for different clinical toxicities. This work provides new translational toxicity relationships beyond AE term-matching, the results of which can be used for risk profiling of future new chemical entities for clinical studies and for the development of future in vitro safety panels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Analytical inconsistencies also arise from the use of different statistical frameworks such as sensitivity, specificity, predictive values, or likelihood ratios, which can yield divergent conclusions (Monticello et al., 2017; Bailey and Balls, 2019; Giblin et al., 2021).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Giblin et al., 2021
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“as repeatedly reported from previous concordance analyses (Clark and Steger-Hartmann, 2018; Giblin et al., 2021).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Giblin et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Of the 188 adverse events that were identified as significant by Giblin et al. analysis, 183 (97%) were also significant in our dataset.”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Giblin et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Lecture Notes in Computer Science 1205
(1999) · Industrial Robot: An International Journal · doi:10.1108/ir.1999.04926fae.001 · Cited by 38,662
On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P
Fisher, R. A. (1922) · Journal of the Royal Statistical Society · doi:10.2307/2340521 · Cited by 2,953
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., Billis, K., Cummins, C., Gall, A., Girón, C. G., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1098 · Cited by 2,605
Entrez Gene: gene-centered information at NCBI
Maglott, D., Ostell, J., Pruitt, K. D., & Tatusova, T. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1237 · Cited by 2,094
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
UniProt Knowledgebase: a hub of integrated protein data
Magrane, M., & Consortium, U. (2011) · Database · doi:10.1093/database/bar009 · Cited by 1,463
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344
The human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C., Vaugeois, J.-M., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J.-J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
InChI, the IUPAC International Chemical Identifier
Heller, S. R., McNaught, A., Pletnev, I., Stein, S., & Tchekhovskoi, D. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0068-4 · Cited by 867
Refining clinical diagnosis with likelihood ratios
Grimes, D. A., & Schulz, K. F. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66422-7 · Cited by 828
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Bowes, J., Brown, A. J., Hamon, J., Jarolimek, W., Sridhar, A., Waldron, G., & Whitebread, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3845 · Cited by 748
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
Are animal models predictive for humans?
Shanks, N., Greek, R., & Greek, J. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-2 · Cited by 677
King, E. A., Davis, J. W., & Degner, J. F. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008489 · Cited by 649
Distinct Narcolepsy Syndromes in Orexin Receptor-2 and Orexin Null Mice
Willie, J. T., Chemelli, R. M., Sinton, C. M., Tokita, S., Williams, S. C., Kisanuki, Y. Y., Marcus, J. N., Lee, C., Elmquist, J. K., Kohlmeier, K. A., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00330-1 · Cited by 645
Modeling sample variables with an Experimental Factor Ontology
Malone, J., Holloway, E., Adamusiak, T., Kapushesky, M., Zheng, J., Kolesnikov, N., Zhukova, A., Brazma, A., & Parkinson, H. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq099 · Cited by 568
eggNOG: automated construction and annotation of orthologous groups of genes
Jensen, L. J., Julien, P., Kuhn, M., von Mering, C., Muller, J., Doerks, T., & Bork, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm796 · Cited by 547
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3269-3 · Cited by 538
Open Targets: a platform for therapeutic target identification and validation
Koscielny, G., An, P., Carvalho-Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1055 · Cited by 504
Human Disease Ontology 2018 update: classification, content and workflow expansion
Schriml, L. M., Mitraka, E., Munro, J., Tauber, B., Schor, M., Nickle, L., Felix, V., Jeng, L., Bearer, C., Lichenstein, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1032 · Cited by 483
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Morgan, P., Brown, D. G., Lennard, S., Anderton, M. J., Barrett, J. C., Eriksson, U., Fidock, M., Hamrén, B., Johnson, A., March, R. E., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.244 · Cited by 452
Evolution of strategies to improve preclinical cardiac safety testing
Gintant, G., Sager, P. T., & Stockbridge, N. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.34 · Cited by 407
Whitebread, S., Hamon, J., Bojanic, D., & Urban, L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03632-9 · Cited by 404
The mammalian phenotype ontology: enabling robust annotation and comparative analysis
Smith, C. L., & Eppig, J. T. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.44 · Cited by 353
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
Rasmussen, S. A., Mazurek, M. F., & Rosebush, P. I. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i4.391 · Cited by 334
Premature ovarian failure in androgen receptor-deficient mice
Shiina, H., Matsumoto, T., Sato, T., Igarashi, K., Miyamoto, J., Takemasa, S., Sakari, M., Takada, I., Nakamura, T., Metzger, D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506736102 · Cited by 331
Animal to human translation: a systematic scoping review of reported concordance rates
Leenaars, C. H. C., Kouwenaar, C., Stafleu, F. R., Bleich, A., Ritskes-Hoitinga, M., De Vries, R. B. M., & Meijboom, F. L. B. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1976-2 · Cited by 314
Genetics of caffeine consumption and responses to caffeine
Yang, A., Palmer, A. A., & de Wit, H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1900-1 · Cited by 309
Pharmacological causes of hyperprolactinemia.
Torre, D. L., & Falorni, A. (2007) · PubMed Central · Cited by 287
Rétey, J. V., Adam, M., Khatami, R., Luhmann, U. F. O., Jung, H. H., Berger, W., & Landolt, H.-P. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100102 · Cited by 278
(2007) · Choice Reviews Online · doi:10.5860/choice.44-4794 · Cited by 259
Mouse Genome Database (MGD)-2018: knowledgebase for the laboratory mouse
Smith, C. L., Blake, J. A., Kadin, J. A., Richardson, J. E., Bult, C. J., & the Mouse Genome Database Group (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1006 · Cited by 219
Törnqvist, E., Annas, A., Granath, B., Jalkesten, E., Cotgreave, I., & Öberg, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101638 · Cited by 198
Animal models of sleep disorders.
Toth, L. A., & Bhargava, P. (2013) · Europe PMC (PubMed Central) · Cited by 194
An analysis of the use of animal models in predicting human toxicology and drug safety
Bailey, J., Thew, M., & Balls, M. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200306 · Cited by 182
Torner, L. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00025 · Cited by 175
Spotfire: an information exploration environment
Ahlberg, C. (1996) · ACM SIGMOD Record · doi:10.1145/245882.245893 · Cited by 172
Are animal models as good as we think?
Wall, R. J., & Shani, M. (2007) · Theriogenology · doi:10.1016/j.theriogenology.2007.09.030 · Cited by 169
A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans
Clark, M., & Steger-Hartmann, T. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.04.018 · Cited by 162
Tang, J., Tanoli, Z.-U.-R., Ravikumar, B., Alam, Z., Rebane, A., Vähä-Koskela, M., Peddinti, G., van Adrichem, A. J., Wakkinen, J., Jaiswal, A., et al. (2018) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.11.009 · Cited by 154
A review of the role of orexin system in pain modulation
Razavi, B. M., & Hosseinzadeh, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.053 · Cited by 144
Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models
Irukayama-Tomobe, Y., Ogawa, Y., Tominaga, H., Ishikawa, Y., Hosokawa, N., Ambai, S., Kawabe, Y., Uchida, S., Nakajima, R., Saitoh, T., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700499114 · Cited by 140
Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice
Mochizuki, T., Arrigoni, E., Marcus, J. N., Clark, E. L., Yamamoto, M., Honer, M., Borroni, E., Lowell, B. B., Elmquist, J. K., & Scammell, T. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012456108 · Cited by 137
BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results
Visser, U., Abeyruwan, S., Vempati, U., Smith, R. P., Lemmon, V., & Schürer, S. C. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-257 · Cited by 128
OAE: The Ontology of Adverse Events
He, Y., Sarntivijai, S., Lin, Y., Xiang, Z., Guo, A., Zhang, S., Jagannathan, D., Toldo, L., Tao, C., & Smith, B. (2014) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-5-29 · Cited by 128
A Terminological and Ontological Analysis of the NCI Thesaurus
Smith, B., Goldberg, L., & Ceusters, W. (2005) · Methods of Information in Medicine · doi:10.1055/s-0038-1634000 · Cited by 126
Association of the cannabinoid receptor gene (CNR1) with ADHD and post‐traumatic stress disorder
Lu, A. T., Ogdie, M. N., Järvelin, M., Moilanen, I. K., Loo, S. K., McCracken, J. T., McGough, J. J., Yang, M. H., Peltonen, L., Nelson, S. F., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30693 · Cited by 115
Extrapolation of animal toxicity to humans: Interspecies comparisons in drug development
Voisin, E., Ruthsatz, M., Collins, J. M., & Hoyle, P. C. (1990) · Regulatory Toxicology and Pharmacology · doi:10.1016/s0273-2300(05)80052-2 · Cited by 109
Animal models in the study of vomiting
King, G. L. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-040 · Cited by 107
SuperDRUG2: a one stop resource for approved/marketed drugs
Siramshetty, V. B., Eckert, O. A., Gohlke, B.-O., Goede, A., Chen, Q., Devarakonda, P., Preißner, S., & Preißner, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1088 · Cited by 104
Potential functional and pathological side effects related to off-target pharmacological activity
Lynch, J. J., Vleet, T. R. V., Mittelstadt, S. W., & Blomme, E. A. G. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.02.020 · Cited by 102
The Role of Adenosine Receptors in Psychostimulant Addiction
Ballesteros-Yáñez, I., Castillo, C. A., Merighi, S., & Gessi, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00985 · Cited by 94
Thalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Lepper, E., Smith, N., Cox, M., Scripture, C., & Figg, W. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017777 · Cited by 92
Opportunities for the replacement of animals in the study of nausea and vomiting
Holmes, A., Rudd, J., Tattersall, F., Aziz, Q., & Andrews, P. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00176.x · Cited by 86
Tamaki, C., Nagayama, T., Hashiba, M., Fujiyoshi, M., Hizue, M., Kodaira, H., Nishida, M., Suzuki, K., Takashima, Y., Ogino, Y., et al. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.581 · Cited by 79
Evaluation of a clinical test. II: Assessment of validity
Chien, P. F. W., & Khan, K. S. (2001) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2001.00128.x · Cited by 78
Ietswaart, R., Arat, S., Chen, A. X., Farahmand, S., Kim, B., DuMouchel, W., Armstrong, D., Fekete, A., Sutherland, J. J., & Urban, L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102837 · Cited by 78
Foundations for a realist ontology of mental disease
Ceusters, W., & Smith, B. (2010) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-1-10 · Cited by 77
Abramov, U., Raud, S., Kõks, S., Innos, J., Kurrikoff, K., Matsui, T., & Vasar, E. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.03.027 · Cited by 72
Bugelski, P. J., & Martin, P. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01811.x · Cited by 71
Gentile, T. A., Simmons, S. J., Watson, M. N., Connelly, K. L., Brailoiu, E., Zhang, Y., & Muschamp, J. W. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.158 · Cited by 69
Drug-Induced Sleep Disturbances: Focus on Nonpsychotropic Medications
Novák, M., & Shapiro, C. M. (1997) · Drug Safety · doi:10.2165/00002018-199716020-00005 · Cited by 67
Van Vleet, T. R., Liguori, M. J., Lynch, III, Rao, M., & Warder, S. (2019) · SLAS Discovery · doi:10.1177/2472555218799713 · Cited by 59
Roberts, R. A., Aschner, M., Calligaro, D. O., Guilarte, T. R., Hanig, J. P., Herr, D. W., Hudzik, T. J., Jeromin, A., Kallman, M. J., Liachenko, S. M., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv188 · Cited by 58
Fay, K. A., Villeneuve, D. L., Swintek, J., Edwards, S. W., Nelms, M. D., Blackwell, B. R., & Ankley, G. T. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy049 · Cited by 56
Azizi, H., Mirnajafi‐Zadeh, J., Rohampour, K., & Semnanian, S. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.050 · Cited by 55
Pathbase and the MPATH Ontology
Schofield, P. N., Gruenberger, M., & Sundberg, J. P. (2010) · Veterinary Pathology · doi:10.1177/0300985810374845 · Cited by 54
Bailey, J., & Balls, M. (2019) · BMC Medical Ethics · doi:10.1186/s12910-019-0352-3 · Cited by 51
Murrell, D. S., Cortes-Ciriano, I., van Westen, G. J. P., Stott, I. P., Bender, A., Malliavin, T. E., & Glen, R. C. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0086-2 · Cited by 50
Self-citationThe medical dictionary for drug regulatory affairs (MEDDRA) project
Wood, K. (1994) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630030105 · Cited by 48
Filardi, M., Pizza, F., Tonetti, L., Antelmi, E., Natale, V., & Plazzi, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182085 · Cited by 48
Phase i trials in melanoma: A framework to translate preclinical findings to the clinic
Kim, E., Rebecca, V. W., Smalley, K. S. M., & Anderson, A. R. A. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.07.024 · Cited by 44
Associations between androgen receptor CAG repeat length and sperm morphology
Milatiner, D. (2004) · Human Reproduction · doi:10.1093/humrep/deh251 · Cited by 42
ANTIRHEUMATIC MEDICATION IN PREGNANCY
Needs, C. J., & Brooks, P. (1985) · Lara D. Veeken · doi:10.1093/rheumatology/24.3.282 · Cited by 42
Influence of naloxone upon motor activity induced by psychomotor stimulant drugs
Jones, D. N. C., & Holtzman, S. G. (1994) · Psychopharmacology · doi:10.1007/bf02244839 · Cited by 37
Glucocorticoid therapy and adrenal suppression
Benc, D., Ičin, T., Pejaković, S., Bajkin, I. A., Prodanović, J., Vuković, B., Novaković-Paro, J., Tomić-Naglić, D., Zvezdin, B., & Mitrović, M. (2017) · Medicinski pregled · doi:10.2298/mpns1712465b · Cited by 37
Prediction of clinical risks by analysis of preclinical and clinical adverse events
Clark, M. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.02.008 · Cited by 36
Genetics of hereditary neurological disorders in children.
Huang, Y. M., Yu, S., Wu, Z., & Tang, B. (2014) · PubMed · doi:10.3978/j.issn.2224-4336.2014.03.04 · Cited by 36
Castelli, M., Federici, M., Rossi, S., Chiara, V. D., Napolitano, F., Studer, V., Motta, C., Sacchetti, L., Romano, R., Musella, A., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07876.x · Cited by 33
Development ofin vivodrug-induced neurotoxicity models
Sharma, H. S., Menon, P. K., Lafuente, J. V., Muresanu, D. F., Tian, Z. R., Patnaik, R., & Sharma, A. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.970168 · Cited by 28
OMIT: Dynamic, Semi-Automated Ontology Development for the microRNA Domain
Huang, J., Dang, J., Borchert, G. M., Eilbeck, K. L., Zhang, H., Xiong, M., Jiang, W., Wu, H., Blake, J. A., Natale, D. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100855 · Cited by 28
Ovarian Steroidogenesis and Serum Androgen Levels in Patients with Premature Ovarian Failure
Bachelot, A., Méduri, G., Massin, N., Misrahi, M., Kuttenn, F., & Touraine, P. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1734 · Cited by 28
Practical approaches for evaluating adrenal toxicity in nonclinical safety assessment
Inomata, A., & Sasano, H. (2015) · Journal of Toxicologic Pathology · doi:10.1293/tox.2015-0025 · Cited by 27
Bidwell, L. C., Garrett, M. E., McClernon, F. J., Fuemmeler, B. F., Williams, R. B., Ashley‐Koch, A. E., & Kollins, S. H. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr125 · Cited by 26
Influence of adenosine receptor agonists on benzodiazepine withdrawal signs in mice
Listos, J., Malec, D., & Fidecka, S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.025 · Cited by 20
Analysis of the ToxCast Chemical-Assay Space Using the Comparative Toxicogenomics Database
Hu, B., Gifford, E., Wang, H., Bailey, W., & Johnson, T. (2015) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00369 · Cited by 18
Dönitz, J., & Wingender, E. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00197 · Cited by 16
Drug Development and Nonclinical to Clinical Translational Databases
Monticello, T. M. (2014) · Toxicologic Pathology · doi:10.1177/0192623314557189 · Cited by 14
Effects of cholecystokinin on morphine-elicited hyperactivity in hamsters
Schnur, P., Cesar, S. S., Foderaro, M. A., & Kulkosky, P. J. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90131-k · Cited by 11
Targeting the orexinergic system: Mainly but not only for sleep-wakefulness therapies
Ghanemi, A., & Hu, X. (2015) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2014.07.002 · Cited by 10
Kayser, V., Idänpään-Hekkilä, J. J., Christensen, D., & Guilbaud, G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00012-5 · Cited by 10
Association between male infertility and androgen receptor mutations in Brazilian patients
Melo, C. O. A., Danin, A. R., Silva, D. D. M. E., Tacon, J. A., Moura, K. K. V. O., Costa, E. O. A., & da Cruz, A. D. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-1gmr661 · Cited by 6
Research works printed but not linked: 16
- (16) Deaton, Aimee M.; Fan, Fan; Zhang, Wei; Nguyen, Phuong A.; Ward, Lucas D.; Nioi, Paul. Rationalizing Secondary Pharmacology Screening Using Human Genetic and Pharmacological Evidence. Toxicol. Sci. 2019 , 167 , 593-603. -
- (20) Nissen, David. Mosby's Drug Consult , 13th ed.; Mosby, 2007. -
- (21) Reed Elsevier Properties SA. PharmaPendium https://pharmapendium.com/ (accessed Jun 4, 2018). -
- (39) Süleyman, Halis; Demircan, Berna; Karagöz, Yalçin. Anti-Inflammatory and Side Effects of Cyclooxygenase Inhibitors. Pharmacol. Reports 2007 , 59 , 247-258. -
- (43) Ahmadian, Maryam; Suh, Jae Myoung; Hah, Nasun; Liddle, Christopher; Atkins, Annette R.; Downes, Michael; Evans, Ronald M. Pparγ Signaling and Metabolism: The Good, the Bad and the Future. Nat. Med. 2013 , 19 , 557-566. -
- (55) Whitebread, Steven; Hamon, Jacques; Bojanic, Dejan; Urban, Laszlo. Keynote Review: In Vitro Safety Pharmacology Profiling: An Essential Tool for Successful Drug Development. Drug Discov. Today 2005 , 10 , 1421-1433. - · DOI · Paper page
- (56) Santos, Cynthia; Olmedo, Ruben E. Sedative-Hypnotic Drug Withdrawal Syndrome: Recognition And Treatment. Emerg. Med. Pract. 2017 , 19 , 1-20. -
- (63) Haughey, Heather M.; Marshall, Erin; Schacht, Joseph P.; Louis, Ashleigh; Hutchison, Kent E. Marijuana Withdrawal and Craving: Influence of the Cannabinoid Receptor 1 ( CNR1 ) and Fatty Acid Amide Hydrolase ( FAAH ) Genes. Addiction 2008 , 103 , 16781686. -
- (72) Komori, Shinji; Kasumi, Hiroyuki; Sakata, Kazuko; Koyama, Koji. The Role of Androgens in Spermatogenesis. Soc. Reprod. Fertil. Suppl. 2007 , 63 , 25-30. -
- (78) Brown, Elliot G.; Wood, Louise; Wood, Sue. The Medical Dictionary for Regulatory Activities (MedDRA). In Drug Safety ; John Wiley & Sons, Ltd: Chichester, UK, 1999; Vol. 20, pp 109-117. -
- (81) Li, Wentian. Mutual Information Functions Versus Correlation Functions in Binary Sequences. J. Stat. Phys. 2012 , 60 , 249-252. -
- (89) Berthold, Michael R.; Cebron, Nicolas; Dill, Fabian; Gabriel, Thomas R.; Kötter, Tobias; Meinl, Thorsten; Ohl, Peter; Thiel, Kilian; Wiswedel, Bernd. KNIME - the Konstanz Information Miner. In ACM SIGKDD Explorations Newsletter ; Preisach C., Burkhardt H., Schmidt-Thieme L., Decker R., Ed.; Springer: Berlin, Heidelberg, 2009; Vol. 11, p 26. -
- (90) Krejsa, Cecile M.; Horvath, Dragos; Rogalski, Sherri L.; Penzotti, Julie E.; Mao, Boryeu; Barbosa, Frédérique; Migeon, Jacques C. Predicting ADME Properties and Side Effects: The BioPrint Approach. Curr. Opin. Drug Discov. Devel. 2003 , 6 , 470-480. -
- (107) Mungall, Christopher J.; Koehler, Sebastian; Robinson, Peter; Holmes, Ian; Haendel, Melissa. K-BOOM: A Bayesian Approach to Ontology Structure Inference, with Applications in Disease Ontology Construction. bioRxiv 2019 , 048843. -
- (108) Mohammed, Osama; Benlamri, Rachid; Fong, Simon. Building a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach. In 1st International Conference on Future Generation Communication Technologies, FGCT 2012 ; IEEE, 2012; pp 104-108. -
- (116) Mungall, Christopher J.; McMurry, Julie A.; Köhler, Sebastian; Balhoff, James P.; Borromeo, Charles; Brush, Matthew; Carbon, Seth; Conlin, Tom; Dunn, Nathan; Engelstad, Mark; Foster, Erin; Gourdine, J. P.; Jacobsen, Julius O. B.; Keith, Dan; Laraway, Bryan; Lewis, Suzanna E.; NguyenXuan, Jeremy; Shefchek, Kent; Vasilevsky, Nicole; et al. The Monarch Initiative: An Integrative Data and Analytic Platform Connecting Phenotypes to Genotypes across Species. Nucleic Acids Res. 2017 , 45 , D712-D722. -
Cited by
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Nada, H., Choi, Y., Kim, S., Jeong, K. S., Meanwell, N. A., & Lee, K. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02036-3 · Cited by 216
“163,164 Meanwhile, immunogenicity refers to the development of anti-drug antibodies (ADAs) by the patient ’ s immune system in response to the therapeutic mAb.”
Burnett, S. D., Blanchette, A. D., Chiu, W. A., & Rusyn, I. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00203 · Cited by 95
Nada, H., Sivaraman, A., Lu, Q., Min, K. H., Kim, S.-D., Goo, J., Choi, Y., & Lee, K. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01957 · Cited by 49
Introduction to Special Issue: Computational Toxicology
Kleinstreuer, N., Tetko, I. V., & Tong, W. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00032 · Cited by 30
Metadata
- Authors
- Giblin, K. A., Basili, D., Afzal, A. M., Rosenbrier-Ribeiro, L., Greene, N., Barrett, I., Hughes, S. J., & Bender, A.
- Affiliations
- AstraZeneca (United Kingdom) (GB)
- University of Cambridge (GB)
- Safety Platforms, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, United Kingdom
- AstraZeneca (United States) (US)
- Corresponding author
- Giblin, Kathryn A.
- Bender, Andreas
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-12-18
- Volume
- 34
- Issue
- 2
- Pages
- 438-451
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- OpenAlex
- W3117596366
- Cited by
- 18
- References
- 99
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 3
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Chemical Research in Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- AstraZeneca (RG82499)
- FP7 Ideas: European Research Council (336159)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- drug-induced adverse events, animal models, mutagenicity, teratozoospermia, ovarian failure, sleep quality, drug withdrawal syndrome
- MeSH terms
- Animals, Pharmaceutical Preparations, Humans, Molecular Structure, Databases, Factual, Adverse Drug Reaction Reporting Systems, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.